Select Publications
Book Chapters
2022, 'Iodinated Contrast and Acute Kidney Injury', in Evidence-Based Nephrology, Second Edition [2 Volume], pp. 145 - 162, http://dx.doi.org/10.1002/9781119105954.ch11
,2012, 'Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease', in Wang Y (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd009631
,2009, 'Lipid lowering in chronic kidney disease', in Therapeutic Strategies in Lipid Disorders
,Journal articles
2025, 'Clinical prediction models for acute kidney injury', Intensive and Critical Care Nursing, 86, http://dx.doi.org/10.1016/j.iccn.2024.103852
,2024, 'Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials', Critical Care, 28, http://dx.doi.org/10.1186/s13054-024-04877-4
,2024, 'Association of Age, Frailty, and Strategy for Initiation of Renal-Replacement Therapy: A Post Hoc analysis of the STARRT-Acute Kidney Injury Trial', Blood Purification, 53, pp. 781 - 792, http://dx.doi.org/10.1159/000540323
,2024, 'Replacement Strategies for Tunneled Hemodialysis Catheters with Complications: A Nationwide Cohort Study', Clinical Journal of the American Society of Nephrology, 19, pp. 1148 - 1158, http://dx.doi.org/10.2215/CJN.0000000000000495
,2024, 'Clinical Adjudication of Hemodialysis Catheter-Related Bloodstream Infections: Findings from the REDUCCTION Trial', Kidney360, 5, pp. 550 - 559, http://dx.doi.org/10.34067/KID.0000000000000389
,2024, 'Tunneled Hemodialysis Catheter Tip Design and Risk of Catheter Dysfunction: An Australian Nationwide Cohort Study', American Journal of Kidney Diseases, 83, pp. 445 - 455, http://dx.doi.org/10.1053/j.ajkd.2023.09.021
,2024, 'Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis', Critical Care Explorations, 6, pp. E1053, http://dx.doi.org/10.1097/CCE.0000000000001053
,2024, 'Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data', The Lancet Regional Health - Western Pacific, 43, http://dx.doi.org/10.1016/j.lanwpc.2023.100988
,2024, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Kidney International Reports, 9, pp. 312 - 322, http://dx.doi.org/10.1016/j.ekir.2023.11.022
,2024, 'The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis system', Peritoneal Dialysis International, http://dx.doi.org/10.1177/08968608231209850
,2024, 'The predictive value of systemic immune-inflammation index for vascular access survival in chronic hemodialysis patients', Frontiers in Immunology, 15, http://dx.doi.org/10.3389/fimmu.2024.1382970
,2024, 'Assessing the Quality of Care for People with CKD: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.2024bzcfkb63
,2024, 'National Estimates of Direct Health Care Costs Associated with Catheter-Related Bloodstream Infection among Hospitalized Hemodialysis Patients in Australia', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.20246pgrza9p
,2024, 'Use of SGLT2 Inhibitors and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in Australian Primary Care Patients with Type 2 Diabetes Mellitus (T2DM) Stratified by CKD Status', Journal of the American Society of Nephrology, 35, pp. 10.1681/asn.2024f7q40fk1, http://dx.doi.org/10.1681/asn.2024f7q40fk1
,2023, 'Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial', The Lancet, 402, pp. 2077 - 2090, http://dx.doi.org/10.1016/S0140-6736(23)02302-4
,2023, 'A codesigned integrated kidney and diabetes model of care improves patient activation among patients from culturally and linguistically diverse backgrounds', Health Expectations, 26, pp. 2584 - 2593, http://dx.doi.org/10.1111/hex.13859
,2023, 'Impact of Intensity of Continuous Renal Replacement Therapy on Duration of Ventilation in Critically Ill Patients: A Secondary Analysis of the RENAL Trial', Blood Purification, 52, pp. 888 - 897, http://dx.doi.org/10.1159/000533687
,2023, 'Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial', Intensive Care Medicine, 49, pp. 1305 - 1316, http://dx.doi.org/10.1007/s00134-023-07211-8
,2023, 'Effect of a Multifaceted Intervention on the Incidence of Hemodialysis Catheter Dysfunction in a National Stepped-Wedge Cluster Randomized Trial', Kidney International Reports, 8, pp. 1941 - 1950, http://dx.doi.org/10.1016/j.ekir.2023.07.013
,2023, 'Multifaceted Quality Improvement Interventions to Prevent Hemodialysis Catheter–Related Bloodstream Infections: A Systematic Review', American Journal of Kidney Diseases, 82, pp. 429 - 442.e1, http://dx.doi.org/10.1053/j.ajkd.2023.02.006
,2023, 'Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study', European Heart Journal - Quality of Care and Clinical Outcomes, 9, pp. 621 - 631, http://dx.doi.org/10.1093/ehjqcco/qcac069
,2023, 'Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada', Kidney Medicine, 5, http://dx.doi.org/10.1016/j.xkme.2023.100675
,2023, 'Fluid Management for Critically Ill Patients with Acute Kidney Injury Receiving Kidney Replacement Therapy: An International Survey', Clinical journal of the American Society of Nephrology : CJASN, 18, pp. 705 - 715, http://dx.doi.org/10.2215/CJN.0000000000000157
,2023, 'Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial', The Lancet, 401, pp. 1584 - 1594, http://dx.doi.org/10.1016/S0140-6736(23)00569-X
,2023, 'A Process Evaluation of the National Implementation of a Bundle for Central Venous Catheter Care for Hemodialysis', Kidney360, 4, pp. E496 - E504, http://dx.doi.org/10.34067/KID.0000000000000076
,2023, 'Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial (Intensive Care Medicine, (2022), 4 8, 12, (1736-1750), 10.1007/s00134-022-06912-w)', Intensive Care Medicine, 49, pp. 381 - 383, http://dx.doi.org/10.1007/s00134-023-06976-2
,2023, 'Characterization of Risk Prediction Models for Acute Kidney Injury A Systematic Review and Meta-analysis', JAMA Network Open, 6, http://dx.doi.org/10.1001/jamanetworkopen.2023.13359
,2023, 'Comparing survival in patients with chronic kidney disease across three countries – Results from the study of heart and renal protection-extended review', Nephrology, 28, pp. 36 - 43, http://dx.doi.org/10.1111/nep.14127
,2023, 'Effect of kidney disease on all-cause and cardiovascular mortality in patients undergoing coronary angiography', Renal Failure, 45, http://dx.doi.org/10.1080/0886022X.2023.2195950
,2023, 'Prognostic Significance of Baseline Blood Glucose Levels and Glucose Variability in Severe Acute Kidney Injury: A Secondary Analysis from the RENAL Study', Journal of Clinical Medicine, 12, http://dx.doi.org/10.3390/jcm12010015
,2023, 'Burden of Haemodialysis Catheter-Related Bloodstream Infections in Australia: A National Data-Linkage Study', Journal of the American Society of Nephrology, 34, pp. 535 - 535, http://dx.doi.org/10.1681/asn.20233411s1535a
,2023, 'Hemodialysis Catheter Rewiring vs. Removal and Replacement: Post Hoc Analysis of a National Stepped Wedge Cluster Randomized Trial', Journal of the American Society of Nephrology, 34, pp. 534 - 535, http://dx.doi.org/10.1681/asn.20233411s1534c
,2023, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Journal of the American Society of Nephrology, 34, pp. 373 - 373, http://dx.doi.org/10.1681/asn.20233411s1373a
,2023, 'WCN23-0574 THE ELLEN MEDICAL DEVICES AFFORDABLE POINT-OF-CARE PERITONEAL DIALYSIS SYSTEM - A PILOT STUDY', Kidney International Reports, 8, pp. S350 - S350, http://dx.doi.org/10.1016/j.ekir.2023.02.786
,2022, 'Treatment decision-making and care among older adults with kidney failure: Protocol for a multicentre, prospective observational cohort study with nested substudies and linked qualitative research (the Elderly Advanced CKD Programme)', BMJ Open, 12, http://dx.doi.org/10.1136/bmjopen-2022-066156
,2022, 'Dialysis Prevalence in Zimbabwe: A Cross-sectional Descriptive Study', American Journal of Kidney Diseases, 80, pp. 813 - 816, http://dx.doi.org/10.1053/j.ajkd.2022.04.002
,2022, 'Fluid balance and renal replacement therapy initiation strategy: a secondary analysis of the STARRT-AKI trial', Critical Care, 26, http://dx.doi.org/10.1186/s13054-022-04229-0
,2022, 'Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial', Intensive Care Medicine, 48, pp. 1736 - 1750, http://dx.doi.org/10.1007/s00134-022-06912-w
,2022, 'Renal outcomes according to renal replacement therapy modality and treatment protocol in the ATN and RENAL trials', Critical Care, 26, http://dx.doi.org/10.1186/s13054-022-04151-5
,2022, 'The Relationship between Rate and Volume of Intravenous Fluid Administration and Kidney Outcomes after Angiography', Clinical Journal of the American Society of Nephrology, 17, pp. 1446 - 1456, http://dx.doi.org/10.2215/CJN.02160222
,2022, 'The Effect of an Accelerated Renal Replacement Therapy Initiation Is Not Modified by Baseline Risk', ANNALS OF THE AMERICAN THORACIC SOCIETY, 19, pp. 1613 - 1618, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000851401300027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial', CRITICAL CARE, 26, http://dx.doi.org/10.1186/s13054-022-04120-y
,2022, 'Should Corticosteroids Be Used to Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: CON', Kidney360, 3, pp. 1310 - 1313, http://dx.doi.org/10.34067/KID.0007042021
,2022, 'A co-designed integrated kidney and diabetes model of care improves mortality, glycaemic control and self-care', Nephrology Dialysis Transplantation, 37, pp. 1472 - 1481, http://dx.doi.org/10.1093/ndt/gfab230
,2022, 'Optimizing the Design and Analysis of Future AKI Trials', Journal of the American Society of Nephrology, 33, pp. 1459 - 1470, http://dx.doi.org/10.1681/ASN.2021121605
,2022, 'Hyperoncotic Albumin Solution in Continuous Renal Replacement Therapy Patients', Blood Purification, 51, pp. 590 - 599, http://dx.doi.org/10.1159/000517957
,2022, 'Platelet Decreases following Continuous Renal Replacement Therapy Initiation as a Novel Risk Factor for Renal Nonrecovery', Blood Purification, 51, pp. 559 - 566, http://dx.doi.org/10.1159/000517232
,